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ABSTRACT
￿
Normal, unimmunized mouse serum from several strains (BALB/c, C57/b, DBA/2,
NZB, SJL, CD/1) contains an endogenous IgG antibody that localizes to the Golgi complex of
rat pancreatic acinar cells. Treatment of pancreatic acini with 5 AM monensin resulted in the
swelling and vacuolization of the Golgi cisternae, and in a corresponding annular staining by
the mouse serum as observed by immunofluorescence, suggesting that the antigen recognized
is on the Golgi complex cisternal membrane. The antiserum did not react with pancreatic
secretory proteins, and its binding to smooth microsomal membranes was retained following
sodium carbonate washing, supporting a Golgi membrane localization .
Advantage was taken of the existence of the endogenous murine antibody for the isolation
of monoclonal antibodies directed to the Golgi complex of the rat pancreas. Two antibodies,
antiGolgi I and antiGolgi 2, are described. Both antibodies are IgMs that recognize integral
membrane proteins of the trans-Golgi cisternae, with lighter and patchy staining of the
pancreatic lumen membrane, as observed both by light and electron microscopy . AntiGolgi 1
recognizes predominately a protein of molecular weight 103,000-108,000, whereas antiGolgi
2 shows a strong reaction to a 180-kd band as well as the 103-108-kd protein.
The problem of organelle biogenesis may reduce to the ques-
tion ofhow membrane domains are created and maintained.
To answerthis question it is necessary to have specific markers
for membrane antigens which are defined by their localiza-
tion, rather than solely by theirbiochemical properties. Mon-
oclonal antibody techniques offer researchers a relatively
straightforward methodology for the acquisition of probes for
cellular components that are biochemically undefined but
that can be recognized by their desired location, or other
characteristics.
In the course of devising techniques for screening mono-
clonal antibodies to various membrane domains, we observed
an endogenous mouse serum antibody that recognizes integral
membrane antigens of the rat pancreatic Golgi complex (1).
The usefulness ofsuch antibodies for our laboratory's studies
ofmembrane biogenesis prompted us to exploit this discovery,
and to isolate monoclonal antibodies directed to integral
membrane proteins of the trans-Golgi cisternae. Investigators
developing murine monoclonal antibodies should also be
aware that this endogenous antibody is likely to contaminate
ascites fluids containing other monoclonal antibodies of in-
terest.
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MATERIALS AND METHODS
Mouse Sera:
￿
Balb/C, SJL, NZB, DBA/2, and C57/b mice were ob-
tained from Jackson Laboratories (Bar Harbor, ME). CD/ I mice were from
Charles Rivers Laboratories (Wilmington, MA). To obtain small quantities of
normal serum for immunolocalization, mice were anesthetized (Metofane,
Pitman-Moore, Washington Crossing, NJ) and bled from their retro-orbital
sinuses. The blood was clotted overnight at 4°C and spun for 5 min at 18,000
g, after which the supernatant was retained. Larger quantities of mouse serum,
diluted in phosphate-citrate buffer, were donated by J. Gershoni (Weizmann
Institute, Rehovot, Israel). This was precipitated in 50% saturated ammonium
sulfate, anddialyzedagainst 20 mM sodium phosphate buffer, pH 8.0, contain-
ing 5-10 mM EDTA. Recovery ofthe mouse serum IgGs was done on DEAE-
AffLgel Blue (Bio-Rad Laboratories, Richmond, CA) in the above buffer, with
the IgM-containing fraction obtained after elution ofthe column with 0.2 M
NaCI added to the buffer. An IgG fraction of mouse serum was also purchased
from Miles Laboratories Inc., (Kankakee, IL) and an IgM fraction was obtained
from Pel-Freeze Biologicals (Rogers, AR). Mouse IgG Fc molecules were pur-
chased from Jackson Immunoresearch (Avondale, PA).
Mouse antiserum to pancreatic secretory proteins was obtained -I mo after
intraperitoneal immunization of mice with 100 gtg of alum-precipitated secre-
tory proteins.
lmmunofluorescence:
￿
For the examination of the pancreas and
mosttissues, rats (Sprague-Dawley, Charles Rivers Laboratories) were killed by
decapitation, and the organ of interest was dissected out and minced in 3%
paraformaldehyde in PBS (containing 8 mM Na2HP04, 1.5 mM KHZPO4, 3
2035mM KCI, and 140 mM NaCl), pH 7.2. Tissues were fixed for from 2 h to
several days at 4°C. In some cases animals were anesthetized with ether and
perfusedwith the same fixative before dissection and furtherfixation, and 0.1
glutaraldehyde was occasionally addedfor use with the monoclonal antibodies.
After fixation, the tissues were infiltrated with 1.2 M sucrose in 20 mM sodium
phosphate buffer, pH 7.2, and sections of 0.5-1.0 Am were cut at -55° to
-70°C on an ultramicrocryotome (E. I. DuPont de Nemours & Co., Inc.,
Sorvall Instruments Div., Newtown, CT; reference 2) and placed on gelatin-
subbed slides. Slides with tissue sections under 2.3 M sucrose could be stored
at -20° up to 12 mo with no loss ofstructural detail or antigenicity.
Indirect immunofluorescence was done by the general procedure ofCoons
and Kaplan (3). The sucroseoverlaying the sectionswere washed away with 20
mM phosphate buffer, pH 8.0, containing 10-20 mM lysine (wash buffer)
which was changed four times in 0.5 h. The primary antibody was diluted into
20 mM phosphate buffer, pH 8.0, containing 25% goat serum (Gibco Labora-
tories, Grand Island, NY) and 0.3 M NaCl (serum dilution buffer, SDB') and
applied to the sections for 1 h at 25°C. Sections were then washed with four
changesofwash bufferin 0.5 h, and the rhodamine-conjugatedsecond antibody
(goat anti-mouse, Cappel Laboratories, Inc. Cochranville, PA) diluted at 1 :300
in SDB was applied for I h. Sections were again washed, and put into coverslips
under 10% glycerol in phosphate buffer, pH 8.0.
Monensin Treatment:
￿
Ratpancreatawere digested toaciniandsmall
lobules by the method of Schultz et al. (4). These were then washed free of
collagenase by repeated centrifugation through a cushion of 4% BSA and
returned to the Krebs Ringer HEPES buffer used for dissociation. Monensin
(gift of M. Marsh, Yale University) in ethanol was added to this buffer to a
concentration of 5 pM, and the acini were incubated with continuous shaking
and oxygenation every 10 min at 37°C for 2 h. Control acini were incubated
with ethanol alone. After incubation, the tissue was fixed as above for immu-
nofluorescence or with 2% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2,
for processing with Epon embedding and electron microscopy.
Tissue Fractionation:
￿
Smooth microsomal, rough microsomal, and
secretory granule fractions from rat pancreas were isolated by a modification
ofthe method ofTartakoffand Jamieson (5). Pancreata (usually 10-15 g wet
wt) were homogenized with six strokes at 2,000 rpm with a Brendler-type
homogenizer in 6-10 vol of 0.3 M sucrose containing 0.2 mM, phenylmethyl-
sulfonyl fluoride (Sigma Chemical Co., St. Louis, MO), 0.1 mM benzamidine
(Aldrich Chemical Co., Milwaukee, WI), 10 gg/ml leupeptin (Sigma Chemical
Co., 10 Ag/ml pepstatin (Sigma), 20-50 U/ml Trasylol (MobayChemical Corp.,
NY), 50 pg/ml bacitracin (Sigma), 10 AM antipain (Sigma) and 5 mM beta-
mercaptoethanol (Bio-Rad Laboratories). These inhibitors were also added to
the 2 M sucrose used to make the sucrose gradients. For smooth microsomes,
the homogenate was filtered through two layers ofsurgical gauze, and adjusted
to 1.4 M sucrose by addition of 2 M sucrose. This was overlayed with 1.2 M
sucrose and 0.3 M sucrose and spun at 100,000 g for I h in a Beckman Ti 70
rotor (Beckman Instruments Inc., Palo Alto, CA). The smooth microsomes
were collected atthe 1 .2-0.3 M sucrose interfaces. After recovery ofthe smooth
or rough microsomes from thesucrose gradients, the microsomal fractions were
mixed at 2,000 rpm in a Brendler-type homogenizer with an equal volume of
0.4 M sodium carbonate (-0.1 mg/ml final protein concentration) at 4°C (6-
9), and membranes were recovered after centrifugation at 150,000 g. for 0.75
h. These membranes (1-2 mg) were resuspended in distilled water, and soni-
cated (Sonifier, Heat Systems Ultrasonics, Plainview, NY) for 30 s before
storage at -20°. Secretory proteins were obtained by lysis of secretory granules
in 0.2 M sodium carbonate followed by centrifugation at 200,000 g. for 0.5 h
to remove granule membranes. Incubation medium of carbachol-stimulated
lobules was centrifuged in the same manner (10).
Rat pancreas plasmalemma fractions were prepared by the method of
Rosenzweig et al. (11), and washed with sodium carbonate as above.
MonoclonalAntibody Production:
￿
Young male litter-mate mice
(BALB/c, Jackson Laboratories) were immunized intraperitoneally with 100
Al; of a plasmalemma fraction ofrat pancreas which had been precipitated by
the addition of 3% formalin (12). After 1 mo, sera from the mice were screened
by immunofluorescence, and the mouse whose immunostaining of the Golgi
complex was most enhanced compared with the "preimmune"state waschosen
for fusion. This mouse was injected intravenously with 100 kg of smooth
microsomal membranes precipitated with formalin as above, and the spleen
was removed for fusion 3.5 d later. Spleen cells were removed and fused with
P3 x 63Ag8U.I myeloma cells(13) (gift ofI. Mellman, Yale University),plated
into 88 1.77 cm' wells (Costar 24-well plates, Costar, Data Packaging, Cam-
bridge, MA), and cultured according to standard procedures (14). Hybridoma
tissue culture supernatants were screened by enzyme-linked immunosorbent
'Abbreviations used in this paper:
￿
ELISA, enzyme-linked immu-
nosorbent assay; kd, kilodalton; SDB, serum dilution buffer.
2036
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 98, 1984
assay (ELISA) on smooth microsomal membranes with myeloma supernatant
as control, and the top 25 responses were screened further by immunofluores-
cence. Cultures showing the best responses by both measures were cloned by
limiting dilution (15) until all cultures were homogenously positive by ELISA,
and clones were injected into pristane-primed mice for generation of ascites
fluid. Ascites fluid was spun at 100,000 g. for 0.5 h to eliminate aggregates and
fat, but no further attempt was made to purify the antibodies so obtained,
which were stored at -20°C in 50% glycerol and 0.1 % Na azide.
ELISA Analyses:
￿
In general, the method ofEngvall and Perlmann (16)
forthe ELISA was followed. The fractions were adsorbed onto microtiter plate
wells (EIA 1/2 area, Costar) at 5 Ag/50 kl in PBS for at least I h. Plates could
be stored for >>9 mo at -20°C.,Any remaining binding sites on the wells were
blocked with 0.5% BSA (type 5, Sigma) in PBS for 0.5 h, and this was used for
all subsequent washes. The primary antibody was allowed to react in the wells
for 1 h at 25°C, and the amount of bound antibody was detected using a goat
F(ab)'z anti-mouse secondary antibody conjugated to horseradish peroxidase
(Boehringer Mannheim, Indianapolis, IN), or in cases where a rabbit anti-
mouse second antibody was used, witha staphlyococcus protein A-horseradish
peroxidase conjugate (gift ofJ. Gershoni). The o-phenylaminediamine (Sigma)
reaction product was read at 492 nm in a Titertek Multiskan (Flow Laborato-
ties, McLean, VA). Routine controls included wellswithout antigen or primary
antibody (whose values were blanked to zero) and wells without primary
antibody.
Screening ofmonoclonal antibodies and titering of all antibodies was done
by ELISA on smooth microsomal membranes, as was the typing ofantibodies
using subclass specific second antibodies (Litton Bionetics, Kensington, MD).
In instances when pancreatic secretory proteins were to be tested by ELISA, it
was found necessary to include 0.2 M N-acetylglucosamine, 0.2 M galactose,
or 0.2 M alpha-methyl mannoside (all obtained from Sigma) to inhibit binding
by the secretory proteins of the horseradish peroxidase conjugate. Neither
fucose nor sialic acid at 0.2 M was effective in preventing this "nonspecific"
binding. Sodium carbonate washed membrane fractions were devoid of any
sugar-competable binding of either primary antibody or of the secondary
antibodies. Neuraminidase (type X, Sigma) digestion of smooth microsomal
membranes was carried out in the ELISA plate in 0.2 M Na acetate buffer, pH
5.0, with 0.04 M CaC12 and 0.5% BSA for 21 h at 37°C (17). One-half and two
units perwell were used, and the buffer minus the enzyme served asthecontrol.
Electron Microscopic Immunolocalization: Rat pancreata
were minced, and fixed in either 3% paraformaldehyde and 0.1% glutaralde-
hyde or 3% paraformaldehyde alone in 0.1 M sodium phosphate buffer, pH
7.4, with 0.2 M NaCl. This concentrationofsalt in the fixativegreatlyfacilitated
the preservation ofthe Golgi complexes. Fixation was for ,.18 h at 4°C, after
which the tissue was dehydrated at -30°C through a graded series of ethanols
and infiltrated with Lowicryl K4M (Polaron, Watford, UK) (18, 19). Polym-
erization was carried out by long-wavelength UV light (15 W, 360 nm) at
-30°C for 8 h and at 4°C for 18 h. Silver-gold sections were cut, and placed on
Formvar- and carbon-coated nickel grids.
Nonspecific binding sites on the tissue were quenched at room temperature
by floating sections on SDB for 5 min before the application ofthe ascites fluid
for 3 h at 4°C. Sections were washed with PBS prior to application of the
affinity-purified rabbit anti-mouse second antibody (Cappel Laboratories, Inc.,
40 Ag/ml) in SDB for l h at 4°C. After washing, Protein A-gold was applied
(20-nm size, produced by citrate reduction; reference 20) for 1 h at 4°C. After
final washing, staining ofthe sections was done by placinggrids on a saturated
solution ofgallic acid (21) for 10-15 min, followed by uranyl acetate (1 min)
and lead citrate (1 min). Observations were made on a Siemens 102 electron
microscope. Control sections were incubated with the second antibody and
Protein A-gold without any primary antibody, with low-titer mouse serum as
primary antibody, or with commercially obtained IgM at 1 mg/ml.
Antigen Identification: Smooth microsomal membrane proteins
were run on discontinuous SDS polyacrylamide slab gels (22). The configura-
tion of the lanes ofthe gels was oftwo very wide lanes flanking a narrow lane,
with the microsomal proteins in the wide lanes andmolecular weight standards
(Bio-Rad) in the center lane. We transferred each ofthe lanes to two layers of
nitrocellulose membrane (BA 85, Schleicher & Schuell Inc., Keene, NH), in 8
mM Tris-60 mM glycine under conditions described by Gershoni and Palade
(23), taking care to keep all filters equally aligned on all gel lanes. The center-
lane filters were stained with amido black and re-swollen with water before
drying to serve as the molecular weight key for the autoradiograms. In later
experiments, prestained molecular weight standards(BRL, Bethesda, MD) were
transferred to filters to serve as references. The filters to be overlayed (usually
these were small strips of the larger lanes, to facilitate comparison between
antibodies) were quenched overnightat 25°C in 20 mM Tris-HCI, pH 7.5, with
150 mM NaCl and 10% fetal calf serum (24). Incubation with the primary
antibodies and the '"Wabeled (Iodogen, Pierce Chemical Co., Rockford, IL;
reference 25) goat Fab'2 anti-mouse (Boehringer-Mannhemn) or "II-sheep anti-mouse (Cappel) second antibodies was done in the same buffer, at 4°C. After
antibody incubations the filters were washed with the same Tris-saline buffer
without serum at 4°C, where the pH ofthe buffer shifted to 8 .
Total lipid extraction ofsmooth microsomal membranes was done with the
assistance of the laboratory of R . K . Yu (Yale University) . I mg (protein) of
smooth microsomal membranes was sequentially extracted with chloroform/
methanol 1 :1 (l0 vol) and 2:1 (20 vol) . These extracts were pooled and the
solvents were evaporated under N2. The remaining lipids were resolvated in
CHC13/MeOH 1 :2 and lipids were separated from residual proteins over a
silicic acid column (26) .
FIGURE 1
￿
Immunolocalization of endogenous antibodies on rat pancreatic acinar cells . (A) Phase-contrast photomicrograph of a
500-1,000-nm-thick frozen section . (f3) Localization of normal mouse serum (ammonium sulfate precipitated and concentrated) .
Long arrow indicates a Golgi complex area surrounding some secretory granules . Curved arrow points to a lumen, which is
partially and lightly stained . (C) Epon-embedded section (2 Am thick) of pancreas osmium-stained by the method described by
Friend (27) . The Golgi complexes are darkly stained (long arrow), the granules are lightly stained (curved arrow) . Tissue courtesy
of D . Ingber (Harvard Medical School) . Bar, 10 jim . x 1,150 .
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Mouse Serum Antibody
When first observed by immunofluorescence, the apparent
Golgi complex localization of unimmunized mouse serum
was barely above the threshold for detection on sections of
rat pancreas. However, with the improvement of our immu-
nofluorescence technique, the staining became unambigu-
ously localized to the supranuclear region of the acinar cells
where the Golgi complexes are found . Sera from all micewe
have tested (Balb/c, SJL, CD/l, NZB, DBA/2, C57/b) show
the same pattern of localization, as does at least one commer-
cial mouse IgG fraction . In no instance is any variability of
localization seen under the immunofluorescence conditions
described, i.e., no staining is observed of secretory granules,
lumen content, nuclei, or regions ofthe cell containing rough
endoplasmic reticulum, etc . However, when the serum anti-
body is concentrated followingammonium sulfate precipita-
tion, faint staining of the lumen border is visible (Fig . 1, A
and B) .
The consistent lace-like localization of the antigen to an
area in the acinar cell that is apical to the nucleus and rough
endoplasmic reticulum and at the basal fringe of the granule
zone was taken to be prima facie evidence that the Golgi
complex was being recognized, as the pattern of immunoflu-
orescence mimics that of the classical osmium impregnation
of the Golgi complex (Fig. 1 C, ; reference 27) . To gain direct
evidence on this point, we took advantage of the cellular
effects of the drug monensin, which causes a marked dilation
of elements of the Golgi complex (28, 29). Treatment of
dissociated pancreatic acini with 5 AM monensin caused large
vacuoles to be formed in the supranuclear zone occupied by
the Golgi complexes (Fig . 2, A and B) . These vacuoles are
also seen by light microscopy, and correspond with rings of
fluorescence where the anti-Golgi antibody is localized (Fig .
3,A and B). In control acini, treated with the ethanol vehicle
used for the monensin, the localization of the mouse serum
antibody to the unperturbed Golgi complex appeared as be-
fore (Fig . 3, C and D) .
The absence of localization of the apparent anti-Golgi
complex antiserum to other acinar compartments holding
secretory proteins is not due merely to a lack of access, since
mouse antisera raised to pancreatic secretory proteins are
capable of localizing to secretory granules and the content of
the lumens, as well as to the Golgi complex area (Fig . 4, A
and B). In this latter case, however, it cannot be said how
much of the apparent Golgi complex localization is due to
the endogenous activity present in mouse serum, and how
much to the immune response to secretory proteins.
That it is the antibody component of mouse serum that is
binding to the Golgi complex region is established by the
specificities of the anti-mouse second antibodies used for
detection in immunofluorescence and ELISA . In whole
mouse serum the endogenous polyclonal anti-Golgi antibod-
FIGURE 2
￿
Effects of monensin treatment on dissociated pancreatic acinar cells. (A) Epon-embedded section of control acinus
treated with ethanol alone. (B) Epon section of monensin-treated acinus, showing large vacuoles corresponding to the Golgi
complexes (Go) . (A) Bar, 2 jm . x 4,000 . (B) Bar, 1 Am . x 6,000 .
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￿
Localization of unimmunized mouse serum on pancreatic acini with and without treatment with 5 juM monensin for 2
h on the same tissue shown in Fig . 2 . (A and B) Immunolocalization of normal mouse serum on a frozen section of monensin-
treated tissue . Arrows indicate vacuoles corresponding to the Golgi complexes . (C and D) Localization of normal mouse serum
on control acini . Staining of the Golgi area is flattened and appears normal . Bar, 10,um . x 1,150 .
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￿
Control immunolocalizations for nonspecific staining, on semithin frozen sections. (A and B) Localization of mouse
antiserum raised to secretory proteins . Curved arrows are directed to lumens, which are filled with secretion and react brightly
with the antiserum . Long arrow points to an area where punctate staining of secretory granules is observed . Arrowhead denotes
Golgi-like staining (C and D). Localization of monoclonal antibody directed to acinar cell basolateral membranes . Note the
absence of staining similar to that seen in Fig . 1 . Arrow indicates a lumen, which is not stained . Bar, 10Am . x 1,150 .
ies are found to be of the IgG 1, 2, and 3 classes, with no
detectable activity in the IgM fraction . While it is possible
that some component of the rat pancreatic acinar cell Golgi
complex recognizes a domain ofthe mouse antibody proteins
that does not bind antigen, analogous to the operation of the
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Fc-receptor of macrophages (30), this possibility is greatly
reduced by the observation that several monoclonal mouse
IgGs, raised for other studies in progress, show no localization
to the Golgi complex area (Fig. 4, C and D) . These control
mouse IgG monoclonal antibodies (including an anti-acetyl-choline receptor, courtesy Dr. E . Hawrot, Yale University)
were derived from tissue-culture supernatants, since mono-
clonal antibodies raised as ascites fluids contain the endoge-
nous activity, as do as the IgG fractions derived from ascites.
In addition, no Golgi complex localization was seen by im-
munofluorescence of mouse IgG Fc molecules at 5 mg/ml .
Competition of serum antibody binding with 0 .1 M galactose,
or N-acetylglucosamine was ineffective in displacing antibody
localization .
The annular appearance of the anti-Golgi complex local-
ization following monensin treatment, along with the lack of
localization to the secretory granules and lumen content,
provides evidence that the antigen recognized in the Golgi
complex is not a secretory protein . Instead, the antigen is
probably an integral membrane component of the Golgi
complex, since antigenicity is retained after 0.2 M sodium
carbonate washing of pancreatic smooth microsomal mem-
branes. This fraction is enriched with Golgi membranes, since
it is the fraction with the highest antigen activity (with the
mouse serum antibody and also with monoclonal antibodies
ofknown specificity for Golgi membranes, vide infra), and it
shows at least 9- to 10-fold more antibody-binding activity
than rough microsomal membranes. Moreover, using ELISA
methods, preabsorption of the mouse serum with secretory
proteins does not interfere with its ability to bind to carbonate-
washed membranes (Fig. 5) .
The titer ofthe mouse serum antibody is quite low in many
mice, especially those bled immediately or shortly after receipt
from the supplier, being about 4 by immunofluorescence, and
about 32 by ELISA with ammonium sulfate-precipitated and
concentrated mouse serum . The titer of endogenous anti-
Golgi activity in mice that have been housed for some time
can be higher, and we have observed titers as high as 3,125
by immunofluorescence and ELISA in mouse serum from
mice housed in our facility, and as high as 400 by immuno-
fluorescence of nonspecific ascites fluids from other facilities
(courtesy of Dr. P . Kelly, University of Kansas) . Partly be-
FIGURE 5
￿
ELISA analysis of the binding of normal mouse serum to
smooth microsome membranes following absorption with BSA or
secretory proteins (Sec.), compared with the background in the
absence of serum (b.g .) . Ordinant shows the optical density of the
peroxidase-linked color reaction, and is proportional to the amount
of antibody bound to the membranes . Bars represent variance (s') .
cause of this low or variable level of activity, attempts to
determine by biochemical methods the antigen recognized in
the rat pancreas have not yet been successful. The stimulus
giving rise to this endogenous mouse antibody is also un-
known, although it does not seem to be autoimmune since
no comparable localization is observed in mouse pancreas by
immunofluorescence.
An indication ofthe tissue specificities ofthe mouse serum
antibody is shown in Table I, which shows the results of a
survey ofvarious rat tissues . As described above, the antibody
localizes to the Golgi complexes ofthe pancreatic acinar cells,
but whether this is also true for the duct cells could not be
established with certainty. In the parotid, lacrymal, and sub-
mandibular glands, the Golgi complex areas of acinar cells of
all types are positive, and the striated duct cells are negative .
In these tissues, as in the pancreas, the difficulties of unam-
biguously recognizing the nonstriated duct cells in unstained
frozen sections precludes their assessment. However, in the
other tissues surveyed, there is no indication of localization
ofthe antiserum to the Golgi complex or other cell organelles .
The antiserum thus indicates the existence of tissue-specific
specializations in the constitution of the Golgi complex, al-
though we cannot say that the observed specialization is due
to the same antigen everywhere.
Monoclonal Antibodies
The felicitous existence of an endogenous mouse serum
antibody to the membranes of the rat pancreatic Golgi com-
plex suggested it would be relatively simple to generate mon-
oclonal antibodies with the same specificity . The necessity for
doing so rested on two observations . First, although the anti-
bodies are apparently found in all mice, there is no indication
this will always be the case ; and second, the titer of the
antibody is too low for our purposes . Accordingly, we pro-
ceeded to isolate monoclonal antibodies to the Golgi mem-
TABLE I
Rat Tissue Specificities of Anti-Golgi Antibodies
* + denotes presence, 0, absence, and -, not tested . All screenings were
done on 500-1000-nm-thick frozen sections, fixed in formalin .
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Mouse
serum
Monoclonal antiGolgi
1 2
Pancreas
Acinar cells +" + +
Islet cells 0 0 0
Parotid
Acinar cells + + +
Duct cells 0 0 0
Lacrymal
Acinar cells + + +
Duct cells 0 0 0
Submandibular
Acinar cells + + +
Duct cells 0 0 0
Kidney 0 0 0
Liver 0 0 0
Brain 0 0 0
Smooth muscle 0 0 0
Seminiferous tubule 0 0 0
Blood vessels 0 - -
Epididymis 0 - -
Lymph nodes - 0 0
Thyroid - 0 0branes. Initial attempts to do so, using in vitro stimulation of
lymphocytes with lipopolysaccharide (31), did not result in
the detection of any antibodies that were positive by both
ELISA and immunofluorescence . Immunization ofmice with
smooth microsomal membranes led to a suppression of the
serum anti-Golgi response . Ultimately, an immunization pro-
tocol was worked out whereby a mouse was immunized
intraperitoneally with a pancreatic plasmalemmal fraction
containing a small amount of Golgi membranes, boosted
intravenously some months later with smooth microsomal
membranes, and fused 3.5 d later. About 20 positive colonies
were thus obtained, and on the basis ofELISA responses on
carbonate-washed membranes and immunofluorescence two
were chosen for further study, called antiGolgi 1 and antiGolgi
2 . Both monoclonal antibodies are IgMs .
Immunofluorescence using tissue culture supernatants sug-
gested that antiGolgi 2 reacted with only the Golgi complex,
but that antiGolgi 1 localized to the lumenal border as well
as to the Golgi complex .When ascites fluids from both clones
were normalized for equal titers, however, the localization
patterns were the same (Fig . 6). At the dilutions shown in Fig.
6, the staining of the lumen border is faint, sporadic from
lumen to lumen, and it usually encompasses only a portion
ofthe lumen border . At higher concentrations of the antibod-
ies, the outlining of the lumen is brighter and complete. The
staining of the Golgi complex appears saturated at the lower
concentrations ofascites fluid shown in Fig . 6, and hence the
lighter staining at the lumen edge probably reflects a lesser
amount of the antigens at this site .
The titer of the ascites fluid containing the monoclonal
antibodies is sufficiently high (78,000 for antiGolgi 1 and
16,000 for antiGolgi 2, by ELISA) to allow direct confirma-
tion of the Golgi complex localization at the electron micro-
scopic level (Fig . 7). Immunolocalization of the antiGolgi 1
and antiGolgi 2 on sections of Lowicryl K4M-embedded
pancreas reveals the same pattern as that seen by immunoflu-
orescence of both monoclonals as well as of the mouse anti-
serum . However, the finer resolution afforded at the election
microscopic level reveals that both antiGolgi 1 and antiGolgi
2 localize to the lengths of the trans-most cisternae of the
Golgi complex, which are recognizable in tannic acid-treated
Lowicryl sections by their darker staining (not shown) . Both
antibodies often show patchy localization to lumen micro-
villar membrane, and occasionally to entire lumen borders,
but the staining of the lumen content not adjacent to micro-
villar membranes is no higher than background.On occasion,
localization was detected to what appeared to be small vesicles
apparently located beyond the trans-most boundry of the
Golgi complex . These were seen irrespective ofthe concentra-
tion of Protein A-gold used for localization, and may corre-
spond to the hazy punctate appearance of the supra-Golgi
region of acinar cells seen at the light level when higher
concentrations of antibodies or fluorescent secondary are
employed (not shown) . The antigen for antiGolgi 2 is quite
sensitive to 0 .1% glutaraldehyde fixation, and it was necessary
to localize it in tissues fixed solely with paraformaldehyde .
Only background gold is seen over other cell organelles, and
no localization was observed in the absence of the primary
antibody, nor with a nonspecific mouse IgM fraction instead
ofthe monoclonal antibody .
The antigens for antiGolgi 1 and antiGolgi 2 were identified
by antibody overlays of filter-transferred smooth microsomal
membranes. AntiGolgi 1 revealed a diffuse band of from 103
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to 108 kilodaltons (kd) . AntiGolgi 2 bound to two bands, of
180 kd and 103-108 kd (Fig . 8) . The bands detected are very
likely proteins, since chloroform-methanol extracts of total
lipids from smooth microsomal membranes have little anti-
genic activity by ELISA, whereas the nonextractable fraction
has much more activity . Neuraminidase treatment of the
membranes in vitro did not interfere with the subsequent
binding ofeither antibody. Both monoclonal antibodies share
the same tissue distribution of Golgi complex localization as
the mouse serum (Table 1).
DISCUSSION
By immunofluorescence of tissue sections reacted with nor-
mal mouse serum, we observed an antibody that localized to
the Golgi complex area of the rat pancreatic acinar cell .
Further investigation revealed the antibody to be of IgG
classes, and the antigen to be an integral membrane compo-
nent of the Golgi complex, based on immunolocalization
after monensin treatment and the maintenance of antigenicity
after sodium carbonate washing ofthe membranes. The anti-
Golgi complex activity of normal serum is also found to be
directed against other rat tissues, including the parotid, sub-
mandibular, and lacrymal glands. This antibody is present in
a wide variety of mice and appears to be endogenous, though
probably not autoimmune . The variability of endogenous
antibody titers with time and place suggest the recognition of
the rat pancreatic Golgi complexmay be a cross-reaction with
a common viral or bacterial organism found in the murine
environment .
Because ofthe potential usefulness ofsuch an antibody for
our laboratory's investigations of membrane biogenesis, the
endogenous anti-Golgi activity of normal mouse serum was
exploited for the isolation of monoclonal antibodies of the
same specificity. Two monoclonals have been described,
called antiGolgi 1 and antiGolgi 2 . Both antibodies are IgMs
which recognize integral membrane proteins of the rat pan-
creatic acinar cell Golgi complex, and which share the same
tissue distribution of anti-Golgi activity as the normal mouse
serum . Electron microscopic immunolocalization on thin
sections shows both monoclonal antibodies to consistently
localize to the trans-most cisternae of the rat pancreas Golgi
complexes, with patchy localization to the lumen membrane
as well . Despite these commonalities, the two antibodies are
not entirely directed to the same antigens. AntiGolgi 1 rec-
ognized a band on an SDS gel centered at -105 kd, and
AntiGolgi 2 is directed to two protein moieties, at - 180 and
103-108 kd .
Although no anti-Golgi complex activity was observed in
the IgM fraction of normal mouse serum, both monoclonal
antibodies described herein are IgMs . Thismay be coinciden-
tal, since only four of 20 positive hybridoma cultures were
cloned and typed (all were IgMs) ; or it may result from the
particular immunization protocol used in this study. If the
latter is the case, it suggeststhe possibility that mice find some
proteins in the rat pancreatic Golgi complex to be highly
immunogenic, and that a primary immune response was
captured by the fusion . In light of the apparently identical
specificities by immunolocalization of the mouse serum IgGs
and the monoclonal IgMs, it might be surprising that "re-
immunization" of the normal mice with antigens that are
already demonstrably recognized does not result in the prolif-
eration of IgG-specific memory cells, and their capture by
fusion . However, we have observed that the mouse serumantibody is easily suppressable, suggesting a tight regulation
ofthe IgG response . Alternatively, possibly IgM-specific blast
cells were predominant in the spleen at the time of fusion,
and had the fusion been done earlier or later than 3.5 d, IgG
monoclonal antibodies may have been found . Since antiGolgi
1 and antiGolgi 2 both proved to be quite workable, no
attempt was made to capture monoclonal IgGs. The failure
tocapture the endogenous-antibody secretingB cells following
lipopolysaccharide stimulation in vitro may be attributable to
FIGURE 6 Immunolocali-
zation of monoclonal anti-
bodies directed to the
Golgi complex . (A and B)
AntiGolgi 1 at 1 :250 dilu-
tion . Long arrows indicate
a Golgi complex and the
short arrow points to a lu-
men, the border of which
is partially stained . (C and
D) AntiGolgi 2 at 1 :50 di-
lution . Arrowheads denote
the boundary between an
islet of Langerhans (Is) and
acinar tissue. The long ar-
row is directed to a Golgi
complex and the short ar-
row indicates a lumen,
which is partially stained .
Bar, 10 km. x 1,150.
the failure of lipopolysaccharide to interact with more than
about 1/3 of murine B cells (32, 33) .
There have been prior reports of antibodies directed specif-
ically to the Golgi complex . From immunizations with brain
tissue, Lin and Queally (34) reported a monoclonal antibody
to a heat-shock protein which localizes to the Golgi complex
area of the rat pancreas . The antigen recognized by this
antibody may not be an integral membrane component, since
staining in the nucleus is also seen in some cases (35), andwe
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Immunolocalization of antiGolgi 1 on Lowicryl thin sections, which were stained postlocalization with gallic acid,
uranyl acetate, and lead citrate . (A) Low-power field demonstrating heavy Protein A-gold localization of antiGolgi 1 on the trans
face of the Golgi complex (Go) and on the membrane and microvilli of a lumen membrane (lu) . Little staining is apparent over
the secretory granules (g), and occasional aggregates of gold are present . Bar, 1 Am . X 13,500. (B) A higher-power view of the
acinar lumen (Iu) shown in A . The antibody localization is to the microvilli of the lumen membrane, rather than to the content .
Bar, 0.5 Am. X 34,500 . (C) Higher-power view of a Golgi complex (Go), showing the concentration of label on the trans cisternae.
Background gold labeling can be seen over the large secretory granule, a mitochondrion (m), and the rough endoplasmic
reticulum (rer) . Bar, 0.2 dam . X 56,000 . (D) Control localization, using nonspecific IgM instead of the monoclonal antibodies, and
the same concentrations of rabbit anti-mouse and Protein A-gold as in the previous figures . No localization is seen to the lumen
(lu) or to the Golgi complex (Go) . Bar, 0.5,um . X 27,000 .
2044FIGURE 8 (A) SIDS polyacrylamide gel (7.5%) demonstrating the
membrane preparations used for immune overlay . Lane I has
molecular weight markers of 200, 116, 92.5, 66, and 45 kd, in
descending order . Lane 2 is rat pancreatic homogenate . Lane 3
shows smooth microsomes (1 .2-0.3M sucrose interface) . Lane 4 is
the 100 kga, pellet after Na 2CO,washing . Lane 5 showsthe interface
between the Na2CO 3-sucrose solution and distilled water, after
centrifugation at 100 kg a . As no difference wasfound betweenthe
membranes that pelleted and those that floated after the Na2CO 3
wash, both fractions were used . (B) Immune overlays of antiGolgi
1 and antiGolgi 2 on smooth microsomal membranes resolved by
SIDS PAGE (5-20% gradient) and transferred to nitrocellulose .
AntiGolgi 1 shows a major band at -103-108 kd, while antiGolgi 2
has two major bands, at -180 kd and 103-108 kd . Background
staining due to the second antibody may be seen elsewhere.
have seen cross-reactivity in peripheral axons with this anti-
body as well . Louvard et al . (36) have reported the induction
ofa rabbit polyclonal antibody to a 135-kd integralmembrane
protein of the rat Golgi complex . In this latter study, great
care was taken a priori to insure the universality ofthe antigen
among rodent tissues, and no tissue-specific recognitions of
the antiserum were reported. These and other reports (re-
viewed in reference 36) have established that the Golgi com-
plex, like other cell organelles, has specific protein compo-
nents . However, observations of tissue-specific variations in
the proteins composing the Golgi complex apparently have
not been reported. In the present case, tissue specificity of the
anti-Golgi antibodies has resulted from the opaque musings
of the mouse immune system, rather than any attempt to
demonstrate it ab initio. The differential organ localizations
ofanti-Golgi complex activities revealed by the two different
monoclonal antibodies suggests that a number of tissue-spe-
cific membrane antigens exist in the Golgi complex .
We have not determined that the same antigens are recog-
nized by themouse serum and monoclonal antibodies in each
tissue recognized (Table I). Nonetheless, the precise epitope
specificity of the two monoclonal antibodies does establish
that the Golgi complexes of all these tissues have at least two
specific markers distinguishing them from those of all other
tissues. In essence, the antigenic markers appear in acinar
cells of tissues that are embryologically derived from the
endodermal epithelium giving rise to glands communicating
secretions to the digestive tract, with the singular exception of
the liver . This antigenic specialization across tissues of Golgi
complex membrane proteins suggests a possible common
functional specialization as well .
To localize the antigens recognized by the monoclonal
antibodies, we employed post-embedding immunolocaliza-
tion with protein A-colloidal gold on Lowicryl thin sections.
This technique allows localization to all intracellular com-
partments, without the potential artifacts introduced by in-
complete access ofantibodies to organelles or the trapping or
washing away of reaction products (38). Both antiGolgi 1 and
2 localize to the same cellular domains, i.e., the trans-most
cisternae of the Golgi complex, and patches of microvillar
membrane . Although the staining ofthe lumen membrane is
not consistent from lumen to lumen at the antibody concen-
trations we typically use, it is seen consistently with both
antibodies at the light and electron microscopic levels . The
patchy staining at the lumen doubtless represents real varia-
tion in the amount of antigen present, since equal access to
all of the lumen cross-section is afforded by the thin sections
used herein, especially at the electron microscopic level . The
high degree of access also argues against a nonspecific sticking
of antibody to the lumen surface, which would be expected
to be more uniform, and also would be seen with other
monoclonal antibodies. The staining at the lumen is probably
not due to the insertion or incomplete recycling of the secre-
tory granule membranes, since the antigens are not localized
to zymogen granule membranes (cf. reference 39). This is so
even when tissues are very lightly fixed with 3% paraformal-
dehyde, which results in the loss by extraction of the secretory
proteins bordering the granule cell membrane, andmay afford
greater access to the inner face of this membrane . Since in
general the lumen labeling appeared on the external side of
the membrane, it is likely that the antigen in located on the
cisternal face of the Golgi membranes.
On immune overlays of filter-transferred SDS gels, both
antiGolgi 1 and antiGolgi 2 both seem to recognize the same
protein(s) at - 105 kd, and antiGolgi 2 also binds to a band
of 180 kd . While efforts weremade to limit proteolysis during
the preparation of the smooth microsomal membranes (see
Materials and Methods), it cannot be ruled out apriori in any
specific instance . Thus, for either antibody the binding pattern
may represent the proteolytic fragments of a single polypep-
tide, or a common epitope shared among different polypep-
tides. Alternatively, the data from both monoclonal antibod-
ies suggest that at least two different proteins are being local-
izedto the trans-Golgi cisternal membranes, since the epitopes
ofeach monoclonal antiGolgi must be different .
The previous observations showing a limited topography of
other Golgi complex enzymes raise the question ofhow Golgi
domain specificity is created and maintained. Distributions
ofdomain specificities similar to that described in this paper
have been seen for the other integral trans-Golgi membrane
proteins thiamine pyrophosphatase (40) and galactosyl trans-
ferase (41) . While little plasmalemmal localization was seen
for the 135-kd rodent Golgi complex antigen except in coated
pits (42), the immunoperoxidase technique employed may
not have allowed complete detection ofan externally directed
membrane antigen (M . Farquhar, personal communication) .
From these examples, and that ofthe Golgi proteins described
in this paper, it seems that the factors responsible for the
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nae are not completely capable of distinguishing that mem-
brane compartment from the plasmalemma, especially the
apical or canulicular membrane domain (43-46).
The easy availability of mice "preimmunized" to integral
membrane proteins of the Golgi complex, and the concomi-
tant ease of preparing monoclonal antibodies with the same
specificities, can be expected to be most useful for identifying
and analyzing a family of membrane proteins sharing the
same topological domain. The presence of this antibody in
normal mouse serum should also be noted, as it may also
offerthe potential for complicating pre- or nonimmune con-
trols for other monoclonal antibodies (47).
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